theobromine has been researched along with alpha,beta-methyleneadenosine 5'-triphosphate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lupichuk, SM; Tabrizchi, R | 1 |
| Erdélyi, F; Sperlágh, B; Szabó, G; Vizi, ES | 1 |
| Aggarwal, BB; Majumdar, S | 1 |
| Diniz, C; Gonçalves, J; Leal, S | 1 |
| Capasso, A; Gallo, C | 1 |
5 other study(ies) available for theobromine and alpha,beta-methyleneadenosine 5'-triphosphate
| Article | Year |
|---|---|
Vasodilatation produced by adenosine in isolated rat perfused mesenteric artery: a role for endothelium.
Topics: Adenosine; Adenosine Triphosphate; Animals; Endothelium, Vascular; Glyburide; Male; Mesenteric Arteries; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Suramin; Theobromine; Theophylline; Vasodilation; Vasodilator Agents | 1995 |
Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cadmium; Dose-Response Relationship, Drug; Electric Stimulation; Gene Expression; Guinea Pigs; Heart Atria; Hippocampus; In Vitro Techniques; Male; Norepinephrine; omega-Conotoxin GVIA; Presynaptic Terminals; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; RNA; Superior Cervical Ganglion; Tetrodotoxin; Theobromine; Thionucleotides; Time Factors; Tritium; Xanthines | 2000 |
Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Base Sequence; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Folic Acid Antagonists; Gene Expression; Genes, Reporter; HeLa Cells; Humans; I-kappa B Kinase; I-kappa B Proteins; Jurkat Cells; Leucovorin; Methotrexate; NF-kappa B; NF-KappaB Inhibitor alpha; Oligodeoxyribonucleotides; Phosphorylation; Protein Serine-Threonine Kinases; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2B; Theobromine; Thymidine; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; U937 Cells | 2001 |
Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Epididymis; Immunohistochemistry; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Phenethylamines; Prostate; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theobromine; Triazines; Triazoles; Vas Deferens; Xanthines | 2003 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |